Mesa Laboratories (NASDAQ:MLAB) had declared a cash dividend of $0.1600 on Oct 4, 2016. The shares will quote ex-dividend on Nov 28, 2016 and the record date has been fixed for Nov 30, 2016. On Oct 4, 2016 share price, the yield comes out to be 0.5550%. The dividend payable date has been fixed on Dec 15, 2016.
Mesa Laboratories (MLAB) made into the market gainers list on Fridays trading session with the shares advancing 0.18% or 0.21 points. Due to strong positive momentum, the stock ended at $117.21, which is also near the day’s high of $117.54. The stock began the session at $117.54 and the volume stood at 6,627 shares. The 52-week high of the shares is $131.88 and the 52 week low is $77. The company has a current market capitalization of $430 M and it has 36,65,444 shares in outstanding.
Mesa Laboratories(MLAB) last announced its earnings results on Jul 28, 2016 for Fiscal Year 2017 and Q1.Company reported revenue of $21.11M. Analysts had an estimated revenue of $21.48M. Earnings per share were $0.89. Analysts had estimated an EPS of $0.93.
Several Insider Transactions has been reported to the SEC. On Jun 23, 2016, John James Sullivan (President and CEO) sold 4,000 shares at $121.63 per share price.Also, On Jun 8, 2016, Glenn E Adriance (CSMO) sold 3,000 shares at $111.74 per share price.On Mar 9, 2016, H Stuart Campbell (director) sold 280 shares at $90.00 per share price, according to the Form-4 filing with the securities and exchange commission.
Mesa Laboratories Inc. is primarily focused on quality control products. The Company has three segments: Instruments Biological Indicators and Continuous Monitoring. The Company’s Instruments segment designs manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare pharmaceutical food and beverage medical device industrial hygiene environmental air sampling and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes in the hospital dental medical device and pharmaceutical industries. Its Continuous Monitoring segment designs develops and markets systems which are used to monitor various environmental parameters in hospitals pharmaceutical and medical device manufacturers blood banks pharmacies and a number of other laboratory and industrial environments.